APA (7th ed.) Citation

Lin, R., Gong, Y., & Salter, R. (2022). Synthesis of deuterium‐labeled CCR2 antagonist JNJ‐26131300, [4‐(1H‐indol‐ 3‐yl)‐piperidin‐1‐yl]‐{1‐[3‐(3,4,5‐trifluoro‐phenyl)‐acryloyl]‐piperidin‐4‐yl}‐acetic acid. Journal of Labelled Compounds & Radiopharmaceuticals, 65(5), 147. https://doi.org/10.1002/jlcr.3967

Chicago Style (17th ed.) Citation

Lin, Ronghui, Yong Gong, and Rhys Salter. "Synthesis of Deuterium‐labeled CCR2 Antagonist JNJ‐26131300, [4‐(1H‐indol‐ 3‐yl)‐piperidin‐1‐yl]‐{1‐[3‐(3,4,5‐trifluoro‐phenyl)‐acryloyl]‐piperidin‐4‐yl}‐acetic Acid." Journal of Labelled Compounds & Radiopharmaceuticals 65, no. 5 (2022): 147. https://doi.org/10.1002/jlcr.3967.

MLA (9th ed.) Citation

Lin, Ronghui, et al. "Synthesis of Deuterium‐labeled CCR2 Antagonist JNJ‐26131300, [4‐(1H‐indol‐ 3‐yl)‐piperidin‐1‐yl]‐{1‐[3‐(3,4,5‐trifluoro‐phenyl)‐acryloyl]‐piperidin‐4‐yl}‐acetic Acid." Journal of Labelled Compounds & Radiopharmaceuticals, vol. 65, no. 5, 2022, p. 147, https://doi.org/10.1002/jlcr.3967.